X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3554) 3554
Book Review (500) 500
Publication (307) 307
Book Chapter (8) 8
Conference Proceeding (3) 3
Book / eBook (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3385) 3385
humans (2327) 2327
animals (1757) 1757
male (1470) 1470
thiazoles - pharmacokinetics (1310) 1310
thiazoles - pharmacology (1201) 1201
pharmacology & pharmacy (1128) 1128
female (972) 972
thiazoles - therapeutic use (842) 842
rats (758) 758
thiazoles - administration & dosage (757) 757
mice (631) 631
thiazoles - chemistry (605) 605
pharmacokinetics (553) 553
adult (544) 544
thiazoles - adverse effects (485) 485
middle aged (479) 479
administration, oral (468) 468
dose-response relationship, drug (453) 453
chemistry, medicinal (449) 449
thiazoles - blood (347) 347
aged (340) 340
analysis (321) 321
structure-activity relationship (317) 317
thiazoles (299) 299
thiazoles - metabolism (288) 288
meloxicam (269) 269
rats, sprague-dawley (265) 265
oncology (264) 264
in-vitro (256) 256
thiazoles - chemical synthesis (256) 256
drug interactions (244) 244
cell line, tumor (242) 242
biochemistry & molecular biology (240) 240
cancer (231) 231
treatment outcome (231) 231
dogs (223) 223
dasatinib (217) 217
thiazolidinediones (207) 207
chemistry, organic (205) 205
area under curve (204) 204
half-life (198) 198
molecular structure (197) 197
neurosciences (197) 197
drug therapy (191) 191
tetrazolium salts (190) 190
thiazines - pharmacokinetics (188) 188
research (185) 185
thiazines - administration & dosage (179) 179
time factors (179) 179
pharmacology/toxicology (177) 177
biological availability (172) 172
metabolism (169) 169
toxicology (169) 169
abridged index medicus (163) 163
double-blind (163) 163
cell survival - drug effects (162) 162
double-blind method (162) 162
drugs (162) 162
medicine & public health (159) 159
antineoplastic agents - pharmacology (157) 157
care and treatment (156) 156
veterinary sciences (156) 156
cell line (154) 154
pharmacology (154) 154
rats, wistar (152) 152
article (150) 150
anti-inflammatory agents, non-steroidal - pharmacokinetics (149) 149
hematology (148) 148
efficacy (145) 145
adolescent (142) 142
anti-inflammatory agents, non-steroidal - administration & dosage (139) 139
expression (139) 139
chromatography, high pressure liquid (138) 138
safety (138) 138
kinetics (135) 135
therapy (135) 135
young adult (135) 135
tissue distribution (134) 134
piperazines - therapeutic use (130) 130
pyridines - pharmacokinetics (130) 130
drug design (129) 129
aged, 80 and over (127) 127
apoptosis (126) 126
disease models, animal (126) 126
cells, cultured (124) 124
pyridines - therapeutic use (123) 123
in vitro techniques (122) 122
chemistry, multidisciplinary (121) 121
inhibition (121) 121
brain - metabolism (120) 120
cross-over studies (117) 117
dosage and administration (117) 117
pyridines - pharmacology (116) 116
protein binding (115) 115
pyrimidines - therapeutic use (115) 115
pyridines - administration & dosage (114) 114
benzothiazoles (112) 112
schizophrenia (112) 112
derivatives (111) 111
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3503) 3503
German (19) 19
Japanese (12) 12
Chinese (7) 7
Russian (6) 6
French (5) 5
Spanish (4) 4
Danish (3) 3
Croatian (1) 1
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 03/2010, Volume 87, Issue 3, pp. 322 - 329
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 10/2006, Volume 33, Issue 10, pp. 917 - 924
SUMMARY • Non-steroidal anti-inflammatory drugs (NSAIDs) cause renal side-effects. In the present study, we tested the hypothesis that the extent of the renal... 
pharmacokinetics | kidney | non-steroidal anti-inflammatory drugs | cyclo-oxygenase-2 | sodium urinary excretion | cyclo‐oxygenase‐2 | non‐steroidal anti‐inflammatory drugs | Cyclo-oxygenase-2 | Pharmacokinetics | Kidney | Non-steroidal anti-inflammatory drugs | Sodium urinary excretion | GASTROINTESTINAL TOXICITY | PHYSIOLOGY | CYCLOOXYGENASE-2 | RAT | HYPERKALEMIA | PROTEIN-BINDING | MELOXICAM | INTERSPECIES DIFFERENCES | GENTAMICIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY & PHARMACY | Thiazoles - blood | Area Under Curve | Thiazines - administration & dosage | Thiazines - adverse effects | Sulfones - adverse effects | Male | Thiazoles - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - blood | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Dose-Response Relationship, Drug | Cyclooxygenase 2 Inhibitors - adverse effects | Sulfonamides - blood | Lactones - blood | Lactones - pharmacokinetics | Sodium - urine | Lactones - administration & dosage | Pyrazoles - blood | Pyrazoles - pharmacokinetics | Sulfones - blood | Placebos - administration & dosage | Pyrazoles - adverse effects | Thiazines - pharmacokinetics | Kidney - drug effects | Administration, Oral | Cyclooxygenase 2 Inhibitors - administration & dosage | Rats | Thiazines - blood | Celecoxib | Lactones - adverse effects | Placebos - pharmacokinetics | Sulfones - pharmacokinetics | Cyclooxygenase 2 Inhibitors - pharmacokinetics | Rats, Sprague-Dawley | Sulfonamides - pharmacokinetics | Pyrazoles - administration & dosage | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Potassium - urine | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Sulfonamides - adverse effects | Sulfonamides - administration & dosage | Sulfones - administration & dosage | Kidney, drug effects | Lactones, adverse effects | Sulfones, administration and dosage | Thiazoles, administration and dosage | Anti-Inflammatory Agents, Non-Steroidal, pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal, adverse effects | Sodium, urine | Thiazines, blood | Anti-Inflammatory Agents, Non-Steroidal, blood | Lactones, administration and dosage | Cyclooxygenase 2 Inhibitors, adverse effects | Pyrazoles, blood | Sulfonamides, pharmacokinetics | Thiazines, pharmacokinetics | Pyrazoles, administration and dosage | Thiazoles, blood | Sulfonamides, administration and dosage | Cyclooxygenase 2 Inhibitors, administration and dosage | Lactones, pharmacokinetics | Sulfonamides, blood | Cyclooxygenase 2 Inhibitors, pharmacokinetics | Thiazines, adverse effects | Lactones, blood | Thiazoles, adverse effects | Thiazoles, pharmacokinetics | Sulfones, blood | Sulfonamides, adverse effects | Thiazines, administration and dosage | Placebos, pharmacokinetics | Sulfones, pharmacokinetics | Pyrazoles, adverse effects | Placebos, administration and dosage | Potassium, urine | Sulfones, adverse effects | Pyrazoles, pharmacokinetics | Index Medicus
Journal Article
Journal Article
Chemical Communications, ISSN 1359-7345, 03/2016, Volume 52, Issue 22, pp. 4223 - 4226
Two isomorphous cocrystals of nitazoxanide (NTZ) with p-aminosalicylic acid (PASA) and p-aminobenzoic acid (PABA) as well as their alloys were prepared by... 
EFFICACY | CO-CRYSTALS | CHEMISTRY, MULTIDISCIPLINARY | Alloys - chemistry | Animals | Crystallization | Rats | Calorimetry, Differential Scanning | Crystallography, X-Ray | Thiazoles - chemistry | Rats, Sprague-Dawley | Thiazoles - pharmacokinetics | Index Medicus | Medicine | Drugs | Alloys | Bioavailability | Dissolution | Slurries
Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2014, Volume 70, Issue 11, pp. 1339 - 1351
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2009, Volume 63, Issue 4, pp. 615 - 625
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 10/2012, Volume 436, Issue 1-2, pp. 840 - 850
Nanoparticulate drug delivery system possesses distinct advantages for brain drug delivery. However, its amount that reach the brain is still not satisfied.... 
Nanoparticles | Blood–brain barrier (BBB) | Penetratin | Brain targeting | Cell-penetrating peptides | Blood-brain barrier (BBB) | PERMEABILITY SCREEN | BARRIER | CNS DELIVERY | MDCK CELL-LINE | IN-VITRO | TRANSPORT | POLYMERIC NANOPARTICLES | PEPTIDES | PHARMACOKINETICS | INTRACELLULAR DELIVERY | PHARMACOLOGY & PHARMACY | Fluorescent Dyes - pharmacokinetics | Nanoparticles - chemistry | Cell-Penetrating Peptides - pharmacokinetics | Drug Carriers - administration & dosage | Coumarins - chemistry | Male | Polyethylene Glycols - chemistry | Thiazoles - administration & dosage | Drug Carriers - chemistry | Thiazoles - pharmacokinetics | Brain - metabolism | Carrier Proteins - administration & dosage | Madin Darby Canine Kidney Cells | Carrier Proteins - chemistry | Fluorescent Dyes - administration & dosage | Cell-Penetrating Peptides - chemistry | Cell Survival - drug effects | Fluorescent Dyes - chemistry | Coumarins - administration & dosage | Coumarins - pharmacokinetics | Polyethylene Glycols - pharmacokinetics | Rats | Rats, Sprague-Dawley | Mice, Inbred ICR | Polyethylene Glycols - administration & dosage | Brain - drug effects | Animals | Mice, Nude | Dogs | Thiazoles - chemistry | Drug Carriers - pharmacokinetics | Mice | Nanoparticles - administration & dosage | Cell-Penetrating Peptides - administration & dosage | Carrier Proteins - pharmacokinetics | Drugs | Drug delivery systems | Peptides | Vehicles | Index Medicus
Journal Article
British Journal of Surgery, ISSN 0007-1323, 06/2014, Volume 101, Issue 7, pp. 742 - 749
Journal Article
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 12/2012, Volume 40, Issue 12, pp. 2250 - 2255
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 06/2014, Volume 54, Issue 6, pp. 649 - 656
Statins are commonly used medications by HIV-1 patients. Elvitegravir/cobicistat/emtricitabine/tenofovir DF is a single tablet regimen for the treatment of... 
pharmacokinetics | organic anion transporting polypeptide | breast cancer resistance protein | Stribild | statins | elvitegravir | HIV PROTEASE INHIBITORS | INTEGRASE | EMTRICITABINE | CO-FORMULATED ELVITEGRAVIR | INITIAL TREATMENT | TRANSPORT | EFAVIRENZ | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | INFECTION | TENOFOVIR | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Anti-HIV Agents - pharmacology | Fluorobenzenes - pharmacokinetics | Organic Anion Transporters, Sodium-Independent - antagonists & inhibitors | Pyrimidines - blood | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Male | Neoplasm Proteins - antagonists & inhibitors | Carbamates - pharmacokinetics | Fluorobenzenes - pharmacology | Drug Interactions | Organic Anion Transporters, Sodium-Independent - metabolism | Quinolones - pharmacokinetics | Madin Darby Canine Kidney Cells | Solute Carrier Organic Anion Transporter Family Member 1B3 | Carbamates - pharmacology | Organic Anion Transporters - antagonists & inhibitors | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Sulfonamides - pharmacokinetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Pyrimidines - pharmacokinetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Cobicistat | ATP-Binding Cassette Transporters - antagonists & inhibitors | Thiazoles - blood | Cricetulus | Quinolones - pharmacology | Neoplasm Proteins - metabolism | Organic Anion Transporters - metabolism | Thiazoles - pharmacokinetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Quinolones - blood | Sulfonamides - blood | ATP-Binding Cassette Transporters - metabolism | Adult | Female | Anti-HIV Agents - blood | Drug Therapy, Combination | Fluorobenzenes - blood | CHO Cells | Carbamates - blood | Animals | Anti-HIV Agents - pharmacokinetics | Dogs | Thiazoles - pharmacology | Drug Combinations | Rosuvastatin | Dosage and administration | Pharmacokinetics | Analysis | Confidence intervals | Rodents | Index Medicus
Journal Article